Chain Bridge INASDAQ:CBRGNASDAQ FSI:D. Deficient (Issuer failed to meet continued listing requirements)
- LAST PRICE11.2500
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots11.0000/ 9
- Ask / Lots11.5000/ 4
- Open / Previous Close11.1000 / 11.2500
- Day Range
- 52 Week Range
- Volume11,302
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | CBRG |
|---|---|---|
| 09:32 ET | 1000 | 11.1 |
| 09:41 ET | 2000 | 11.16 |
| 09:43 ET | 300 | 11.2 |
| 10:08 ET | 2000 | 11.15 |
| 10:14 ET | 300 | 11.25 |
| 12:18 ET | 4506 | 11.165 |
| 01:51 ET | 200 | 11.25 |
Jul 22, 2024
DJ SPAC Chain Bridge I to Take Phytanix Bio Public, from 6:29PM ET on Monday Jul 22, 2024 by Dow Jones
6:29PM ET on Monday Jul 22, 2024 by Dow Jones*DJ Chain Bridge I To Acquire Phytanix Bio, Creating A New Public Company Focused On Developing Next Generation Cannabinoid And Cannabinoid-like Medicines >CBRG, from 5:45PM ET on Monday Jul 22, 2024 by Dow Jones
5:45PM ET on Monday Jul 22, 2024 by Dow JonesChain Bridge I to Acquire Phytanix Bio, Creating a New Public Company Focused on Developing Next Generation Cannabinoid and Cannabinoid-like Medicines, from 5:45PM ET on Monday Jul 22, 2024 by Dow Jones
5:45PM ET on Monday Jul 22, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Chain Bridge I | 75.6M | 45.7x | --- |
CONX Corp | 75.7M | -37.5x | --- |
Southport Acquisition Corp | 75.3M | 128.9x | --- |
OCA Acquisition Corp | 75.2M | -41.2x | --- |
Swiftmerge Acquisition Corp | 75.0M | 42.2x | --- |
Alphatime Acquisition Corp | 76.4M | 50.4x | --- |
Company Information
Chain Bridge I is a blank check company. The Company is incorporated for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. It intends to focus its efforts in identifying a prospective target company possessing emerging, innovative technology that can help the United States (U.S) government and its allies compete in the national security arena. It intends to focus for companies in various areas, including artificial intelligence and machine learning, autonomous systems; bio-defense, biomaterials and biotechnology; security, particularly cybersecurity; digital intelligence and data; intelligent connectivity; microelectronics, and trusted infrastructure. It has no operations and has generated no revenues.
Contact Information
- Headquarters
- 8 The Green, #17538DOVER, DE, United States 19901
- Phone
- 302-597-7438
- Fax
- ---
Executives
- Chief Executive Officer, Director
- Andrew Cohen
- Chief Financial Officer
- Andrew Kucharchuk
- Independent Director
- Paul Baron
- Independent Director
- Lewis Silberman
- Independent Director
- Daniel Wainstein
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $75.6M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 6.7M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $0.25 |
Book Value | $4.56 |
P/E Ratio | 45.7x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | 21.1x |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
